Pharma sector sees $6.96 billion in global deal activity in May 2025, led by GSK, Shionogi, and Eli…
M&A and venture capital deals in the global healthcare sector declined from the 12-month average, with three transactions…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
India’s pharma startups raise $254.7 million in May 2025: Tracxn
Seed-stage deals dominate as funding surges over fivefold from April, led by PB Healthcare’s $156 million round
India’s pharma funding falls by over 90% YoY in April 2025
Total funding drops to $57.7 million across 14 rounds, with early-stage investments comprising over half the capital deployed
SeQuent–Viyash merger receives stock exchange approvals; NCLT filing underway
The merger will bring together two business verticals—Global Animal Health and an integrated API business
GlobalData forecasts ADC NSCLC market to reach $3.9 bn in 2032
GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…
China’s biopharma commands $30 billion in oncology licensing deals, triples US output in 2024
Significant reforms in clinical development processes and regulatory reviews in China have led to faster drug approvals,…
Cadila Pharmaceuticals launches Empadon (Empagliflozin)
Clinical trials have consistently shown empagliflozin’s efficacy in reducing cardiovascular mortality, heart failure…
Quadria Capital closes oversubscribed $1 bn fund III to advance healthcare across Asia
This latest fundraise is around 60 per cent larger than the firm’s previous $600 million fund raised in 2020
Biocon Biologics, Yoshindo launch Ustekinumab biosimilar in Japan
Ustekinumab, a monoclonal antibody, is approved for the treatment of psoriasis vulgaris and psoriatic arthritis (PsA)
Cipla launches ZEMDRI (Plazomicin) in India, aims to tackle AMR
Plazomicin is a novel anti-microbial with demonstrated activity against multi-drug resistant (MDR) bacteria and clinical efficacy…
Barentz acquires Fengli, China, aims to strengthen market presence
The partnership would further enhance the service and commercial capabilities of Barentz in China while enabling Fengli Group to…
Tezepelumab’s trial results strengthen potential for biomarker-driven biologic therapies in COPD:…
GlobalData’s latest analysis reveals that tezepelumab, evaluated in the Phase IIa COURSE trial, achieved a 26 per cent reduction…
US drug pricing order – Implications for India’s pharma sector
Ravi Shah, Partner, Cyril Amarchand Mangaldas explains that while the policy is designed to cut costs for US patients, its effects…
Gene therapies drive growth of genomics market, says GlobalData
GlobalData’s latest report reveals that the market for genomic therapies is demonstrating significant growth, with sales projected…
Accretion Pharmaceuticals’ IPO opens for subscription, price band set at ₹96-101 per share
Company also raises ₹2.13 crore from Anchor investors
ATMF report reveals that insulin remains out of reach for T1D patients in LMICs, children facing…
ATMF report recommends practical solutions whereby companies can bring about the fundamental shift that is required to scale up…
Trump calls for drug price cuts, order aims to reduce prices by 30-80 per cent
The order gives drugmakers price targets in the next 30 days, and will take further action to lower prices if those companies do…
Accretion Pharmaceuticals’ IPO to open on May 14 2025; Price band fixed at ₹96-101
The company aims to utilise the funds towards purchasing new equipment, upgrading the manufacturing plant and repayment of certain…
HIV market to exceed $32 bn across 7MM in 2033, forecasts GlobalData
Market growth will primarily be driven by the increased uptake of long-acting injectable therapies, as well as the anticipated…
Pharma CRDMO revenue forecasts 13-15 per cent growth amid supply-chain derisking
Resultant strong cash flows will enable Indian CRDMOs to continue capital expenditure (capex), with limited reliance on debt…